The U.S. Food and Drug Administration ( FDA) approved it on 20 July 2012 for use in patients with multiple myeloma who have received at least two prior therapies, including treatment with bortezomib....
SUZHOU KERNEL PHARMACEUTICAL TECHNOLOGY CO., LTD. the subsidiary of TERAY Pharmaceutical Inc. was found in April 2010 and would focusing on the development manufacture and sales of formualtaion, ....
Manufacture through Solid Phase Peptide Synthesis. Lyophilized powder in acetate form. UP, USP NONE GMP
Manufacture through solid-phase peptide synthesis, lyophilized powder form, None GMP